Jun Kurai Selected Research

Jun Kurai Research Topics

Disease

13	Asthma (Bronchial Asthma) 01/2018 - 08/2010
7	Lung Neoplasms (Lung Cancer) 03/2015 - 11/2005
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019 - 09/2003
5	Inflammation (Inflammations) 01/2018 - 01/2014
4	Neoplasms (Cancer) 11/2019 - 11/2004
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 04/2014
2	Airway Remodeling 01/2017 - 06/2015
2	Lung Diseases (Lung Disease) 01/2015 - 01/2006
1	Cholangitis 11/2019
1	Pleural Effusion (Pleural Effusions) 01/2019
1	Eosinophilia 01/2019
1	Infections 01/2019
1	Paragonimiasis 01/2019
1	Hypersensitivity (Allergy) 01/2016
1	Adenocarcinoma of Lung 03/2015
1	Emphysema 04/2014
1	Malignant Mesothelioma 11/2012
1	Diarrhea 10/2007
1	Leukopenia 10/2007
1	Neutropenia 10/2007
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2006
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2006
1	Pruritus (Itching) 01/2006
1	Dyspnea (Shortness of Breath) 01/2006

Drug/Important Bio-Agent (IBA)

4	ErbB Receptors (EGF Receptor)IBA 03/2015 - 03/2007
3	Particulate MatterIBA 01/2018 - 01/2015
3	CytokinesIBA 11/2016 - 01/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2019 - 01/2015
2	TocotrienolsIBA 01/2017 - 06/2015
2	AntioxidantsIBA 01/2017 - 06/2015
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 01/2015
2	Vinorelbine (Navelbine)FDA LinkGeneric 03/2015 - 11/2004
2	Cetuximab (Erbitux)FDA Link 11/2012 - 03/2007
2	Interleukin-2 (IL2)IBA 11/2012 - 03/2007
2	Indicators and Reagents (Reagents)IBA 08/2012 - 08/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2004 - 09/2003
1	Immune Checkpoint InhibitorsIBA 11/2019
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2019
1	NivolumabIBA 11/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Bronchodilator Agents (Bronchodilators)IBA 01/2019
1	Praziquantel (Biltricide)FDA Link 01/2019
1	Fluticasone (Cutivate)FDA LinkGeneric 01/2018
1	Tiotropium Bromide (Spiriva)FDA Link 01/2018
1	Muscarinic AntagonistsIBA 01/2018
1	VitaminsIBA 01/2017
1	Oxidants (Oxidizing Agents)IBA 01/2017
1	LeukotrienesIBA 11/2016
1	AntigensIBA 11/2016
1	SandIBA 10/2015
1	Tocopherols (Tocopherol)IBA 06/2015
1	Tyrosine Kinase InhibitorsIBA 03/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2015
1	Gefitinib (Iressa)FDA Link 03/2015
1	Interleukin-8 (Interleukin 8)IBA 08/2014
1	Biomarkers (Surrogate Marker)IBA 04/2014
1	Apolipoproteins MIBA 04/2014
1	HDL CholesterolIBA 04/2014
1	LipidsIBA 04/2014
1	AllergensIBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 08/2012
1	Air Pollutants (Pollutants, Air)IBA 06/2012
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2007
1	Cisplatin (Platino)FDA LinkGeneric 10/2007
1	Guanine NucleotidesIBA 03/2007
1	Peptides (Polypeptides)IBA 03/2007
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2007
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2007
1	amrubicinIBA 03/2006
1	homochlorocyclizine (homochlorcyclizine)IBA 01/2006
1	Granisetron (Kytril)FDA LinkGeneric 01/2006
1	stearic acid (magnesium stearate)FDA LinkGeneric 01/2006
1	Docetaxel (Taxotere)FDA Link 01/2006
1	Fluorouracil (Carac)FDA LinkGeneric 11/2004

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 03/2015 - 09/2003
2	Therapeutics 01/2019 - 01/2004
1	Combination Drug Therapy (Combination Chemotherapy) 03/2015
1	Biological Therapy 03/2007